Cite
Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer.
MLA
Hong, Shan-Shan, et al. “Follicle-Stimulating Hormone Peptide-Conjugated Nanoparticles for Targeted ShRNA Delivery Lead to Effective Gro-α Silencing and Antitumor Activity against Ovarian Cancer.” Drug Delivery, vol. 25, no. 1, Nov. 2018, pp. 576–84. EBSCOhost, https://doi.org/10.1080/10717544.2018.1440667.
APA
Hong, S.-S., Zhang, M.-X., Zhang, M., Yu, Y., Chen, J., Zhang, X.-Y., & Xu, C.-J. (2018). Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer. Drug Delivery, 25(1), 576–584. https://doi.org/10.1080/10717544.2018.1440667
Chicago
Hong, Shan-Shan, Ming-Xing Zhang, Meng Zhang, Yi Yu, Jun Chen, Xiao-Yan Zhang, and Cong-Jian Xu. 2018. “Follicle-Stimulating Hormone Peptide-Conjugated Nanoparticles for Targeted ShRNA Delivery Lead to Effective Gro-α Silencing and Antitumor Activity against Ovarian Cancer.” Drug Delivery 25 (1): 576–84. doi:10.1080/10717544.2018.1440667.